Kjellmaniella crassifolia Miyabe (gagome) is a brown alga. Oral gagome administration (oral gagome) resulted in significant upregulation of IL-10 and IFN production by Peyer's patch cells. To assess the adjuvant activity of oral gagome, treated mice were subcutaneously injected with ovalbumin (OVA). The production of cytokines from antigen (Ag)-specific T cells in draining lymph nodes (dLN) and their proliferative response were significantly increased as compared with the control group. These enhancements were associated with increased CD44 hi CD62L À activated/memory T cells in dLN as well as upregulation of Ag-specific IgA level in luminal contents. No upregulation of cytokine production by dLN T cells was observed in dectin-1-deficient mice, suggesting that the effect of gagome on cytokine production is largely dependent on the dectin-1 pathway despite its composite constituents. Our findings indicate that gagome is an effective immunomodulator and a potent adjuvant for both the intestinal and the systemic immune response.
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Brown algae are a group of popular foodstuffs that have long been used in the Asian diet. Recently, there has been increasing interest in the use of brown algae as medicines and health foods as they contain several polysaccharides such as alginate, fucoidan, and laminarin. 1, 2) These polysaccharides are considered to have beneficial influences on health. Alginate has been reported to protect cells from apoptosis, 3) to induce the secretion of cytokines, 4) and to regulate the uptake of cholesterol and glucose. 5) Fucoidan has anti-allergic activity 6) and anti-infectious effects against Helicobacter pylori and prion. 7, 8) It is also known to be involved in anti-tumor activity through modulation of the host immune system and induction of apoptosis in cancer cells. 9, 10) Another important polysaccharide found in brown algea is laminarin, a 1,3--D-glucan with -1,6-linked branches. Various biological activities of -glucan have been observed in in vitro and in vivo studies that share common effects with the other polysaccharides named above: inhibition of tumor growth and metastasis, 11) lowering of blood cholesterol 12) and facilitation of wound healing. 13) Most eminently, -glucan plays significant roles in regulating the immune response. 14, 15) Dectin-1 is the receptor of -glucan. It delivers intracellular signals to activate myeloid cells and regulate the subsequent immune response. [16] [17] [18] Previous studies have investigated extensively the role of dectin-1 in the recognition of and the response to fungal -glucan, the main component of fungal cell walls, 19, 20) but there is limited information regarding the ability of dectin-1 on mucosal organs to mediate the functions of -glucan from brown algae.
In the present study, we aimed to elucidate the immunomodulatory effects of orally administered brown algae using Kjellmaniella crassifolia Miyabe (gagome), which is widely distributed in Japan. We also investigated the effects of oral administration of gagome (oral gagome) in regulating antigen (Ag)-specific systemic immune responses to determine whether dectin-1 signaling is involved.
Mice. Specific pathogen-free female BALB/c mice (10-14 weeks old) were purchased from Sankyo Labo Service (Tokyo). Dectin-1-deficient 16) mice on a C57BL/6 background and control C57BL/6 mice were bred at the animal facilities at Japanese National Institute of Advanced Industrial Science and Technology (AIST, Ibaraki, Japan). The mice had free access to standard laboratory chow (Funabashi Farm, Funabashi, Japan) and water. All procedures using mice were reviewed and approved by the Institutional Care Use of Animals Committee of AIST and were performed according to Guidelines for Animal Use and Experimentation of AIST.
Gagome administration and immunization. Gagomes were mixed into the basic powder diet (MM-3, Funabashi Farm, Funabashi, Japan) at a level of 5% wt/wt. In the immunoregulatory experiments, gagomes were administered for 7 d, and the mice were killed to obtain the spleen, mesenteric lymph nodes (mLN), and Peyer's patches (PPs). To assess the ability of gagome to induce the Ag-specific immune response, the mice were subcutaneously immunized with 50 mg of chicken egg ovalbumin (OVA, Sigma-Aldrich, St. Louis, MO) in complete Freund's adjuvant (CFA) containing Mycobacterium tuberculosis H37Ra (Difco, Detroit, MI) at the base of the tail and in the two hind footpads. Gagomes were administered from 7 d before to 7 d after immunization. The mice were killed on the 8th day after immunization.
Sample collection. Blood samples were collected from axillary vessels while the mice were under anesthesia. The serum was isolated and stored at À80 C until used. Intestinal washes were obtained by removing the entire small intestine and washing the contents out with 3 mL of cold PBS solution. The fluid was centrifuged to sediment solid material, and the supernatant was collected stored frozen.
Cell isolation and culture. Spleen, mLN and draining lymph nodes (dLN) (pooled periaoritic, popliteal, and inguinal lymph nodes) were mechanically minced to make a single cell suspension. Cells from PPs were isolated as previously described. 21) Briefly, PPs were removed from the small intestine and pretreated with dithiothreitol-, Hepes-, and EDTA-containing media to remove epithelial cells. The PPs were digested with collagenase (type I, Sigma-Aldrich) and DNase I (Sigma-Aldrich) at 37 C for 1 h. The dissociated tissue was then passed through a 40-mm mesh filter. Freshly isolated cells were cultured in RPMI-1640 supplemented with 10% fetal calf serum, penicillin (100 U/mL), streptomycin (100 mg/mL), 10 mM Hepes, and 50 mM 2-mercaptoethanol. They were stimulated with anti-CD3 mAb (eBioscience, San Diego, CA) for 48 h or with OVA for 72 h.
Cytokine analysis by ELISA. The amount of cytokines in the supernatant was measured using mouse IL-10 and IFN BD OptEIA ELISA sets (BD Pharmingen, San Diego, CA) or mouse IL-17 DuoSets (R&D systems, Minneapolis, MN) following the manufacturers' instructions. Cytokine concentrations were calculated using the standard curve obtained for each ELISA plate.
In vitro proliferation assays. Cells (5 Â 10 5 /well) were cultured in the presence and the absence of OVA for 72 h. Cell proliferation was assayed using a CCK-8 Kit (Dojindo, Gaithersburg, MD). Aliquots of 20 mL of reagent were added to the wells and incubated at 37 C in a 5% CO 2 incubator for 2 h. The absorbance at 450 nm was measured with a microplate reader (Infinite M200, Tecan, Mannedorf, Swizerland).
OVA-specific antibody (Ab) detection by ELISA. The OVA-specific Ab levels of the serum and intestinal washes were measured by ELISA as previously described. 22) Briefly, 96-well plates (Nalge Nunc, Rochester, NY) were coated with 50 mL of 0.5 mg/mL OVA in PBS overnight at 4 C and blocked with 1% BSA in PBS for 1 h at room temperature. The samples were added to the wells and incubated for 2 h at 37 C. After washing, plates were incubated with biotin-conjugated anti-mouse IgA, IgG, or IgM (Southern Biotechnology Associates, Birmingham, AL). Horseradish peroxidase-conjugated streptavidin was added to each well. After incubation with 100 mL of TMB (3, 3 0 ,5,5 0 -tetramethylbenzidine) liquid substrate for 10-30 min, the enzyme reaction was terminated by adding 50 mL of 2 N H 2 SO 4 . The absorbance at 450 nm was measured with a microplate reader (Tecan Infinite M200).
Flow cytometry analysis. Single-cell suspensions were washed with PBS containing 0.5% BSA. Non-specific staining was prevented by blocking the cells with anti-CD16/CD32 Ab (2.4G2; BD Pharmingen). The cells were stained with the following antibodies for 30 min: antimouse CD4 (clone: RM4-5), anti-mouse CD8 (clone: 53-6.7), antimouse CD44 (clone: IM-7), and anti-mouse CD62L (clone: MEL-14). Flow cytometry was performed using FACSAria (BD Bioscience), and data were analysed using FlowJo software (Tree Star, Ashland, OR).
Statistical analysis. The statistical significance of differences was calculated by Student's t-test. A p value of less than 0.05 was considered statistically significant.
Results
Effect of gagome on cytokine production in nonimmunized mice
First we firstly evaluated the effects of oral gagome on the intestinal cellular immune response in nonimmunized mice. The mice fed gagome showed markedly increased production of IL-10 and IFN by PP cells as compared with those fed the control diet, but gagome did not affect the production of IL-17. In the spleen and mLN, no significant difference was observed between the two groups ( Fig. 1) . These findings indicate that the T lymphocytes in PPs were more responsive to gagome.
Effects of gagome on OVA-specific proliferative response and cytokine production Next we examined the adjuvant effects of gagome. Oral gagome induced an enhanced OVA-specific proliferative response by the dLN cells but not the spleen, mLN, or PP cells. The amounts of Ag-specific IL-10, IFN, and IL-17 secreted by the dLN cells and of IL-10 by the mLN cells from gagome-fed mice were significantly higher than from control mice. Pretreatment with gagome reduced the levels of IL-10 in PP, of IFN in mLN, and of IL-17 in the spleen (Fig. 2) .
Effects of gagome on OVA-specific antibodies We also assessed the influence of oral gagome in enhancing the humoral immune response, and found that the titers of OVA-specific IgA, IgG, and IgM Abs in the sera were not affected (Fig. 3B, C, and D) . To determine the effects of gagome on mucosal sites, OVA-specific IgA Ab titers in the intestinal washes were examined. Surprisingly, OVA-specific IgA Ab was notably enhanced when the mice in the oral gagome group were immunized with OVA, whereas only a minimal amount of it was detected in the intestine by OVA immunization by itself (Fig. 3A) . These findings indicate that oral gagome was more effective for induction of the Agspecific mucosal IgA response than for the systemic humoral response.
Gagome administration enhanced Ag-specific activated/ memory CD4 þ and CD8 þ T cells Gagome-fed mice showed an enhanced proliferative response and enhanced cytokine production in dLN and IgA secretion in the intestinal wash after immunization (Figs. 2 and 3 ). Hence we investigated the change in expression of CD44 and CD62L, both of which were modulated following T cell activation. 23, 24) The percentage of CD44
hi CD62L À cells among the CD4 þ cells with the activated and memory phonotypes was significantly increased in the dLN and slightly in the mLN cells from the gagome-fed mice as compared with the control mice. An increased percentage of CD44 hi CD62L À was also observed for CD8 þ T cells in lymph node cells in the gagome-fed mice (Fig. 4) .
The adjuvant function of gagome was dectin-1 dependent -Glucan is an abundant component of gagome and dectin-1 is a major receptor for -glucan. 19) Hence we investigated whether the adjuvant activity of gagome is dectin-1 dependent using dectin-1-deficient C57BL/6 mice. Oral gagome increased the production of IL-10 by 3.46-fold, of IFN by 1.21-fold, and of IL-17 by 1.70-fold in C57BL/6 wild-type mice (Fig. 5) . This was similar to the findings for BALB/c mice. However, in the dectin-1-deficient mice, gagome failed to induce OVA-specific IL-10, IFN, or IL-17 production, suggesting that the gagome-induced Ag-specific immune response is dependent on the dectin-1 pathway. Basal production of cytokines in the Ag-specific response was higher in the dectin-1-deficient mice than in the wildtype mice.
Discussion
How the luminal environment influences the mucosal and the systemic immune response is a widely recognized question of increasing importance. The effects of commensal flora on T-cell functioning is highly significant, and specific bacteria strains such as Bacteroides, segmented filamentous bacteria, and Chrostridium have been identified as strong modulators of IFN-and IL-10 producing T cells, Th17, and Foxp3 þ regulatory T cells respectively. [25] [26] [27] [28] As major luminal contents, especially of small intestine, components of the normal diet should stimulate innate immune cells and provide a link between food components and specific immunity. Here we found that oral gagome markedly enhanced cytokine production and intestinal OVA-specific IgA Ab after systemic immunization, indicating that it is a good adjuvant for the induction of mucosal and systemic immunity.
IgA is the main immunoglobulin of the mucosal immune system. It provides an anti-infectious protection mechanism by neutralizing pathogens and their toxins, preventing pathogens from binding to mucosal surfaces, and enhancing the protective effects of other immune factors. [29] [30] [31] [32] Therefore, administration of gagome is suggested to be beneficial in preventing intestinal infectious diseases. We observed that increased IgA secretion was accompanied by enhanced cytokine production and the activation of T cells. The enhancement of OVA-specific IgA was 12.77 times while the increased ratio of total IgA was merely 1.86 (data not shown) higher after oral gagome administration than after control diet administration. These results indicate the existence of an antigen-specific T helper-cell mechanism in IgA production. It is speculated that stimulation of innate immune cells with gagome not only raises the polyclonal IgA level by upregulating the T cell independent mechanism mediated through cytokines such as the proliferation-inducing ligand and B cell-activating factor of the tumor necrosis factor family, but also contributes to upregulating the T cell dependent mechanism by actively modulating OVA-specific T cells. The details as to how oral gagome activates T cell dependent and independent IgA production are under investigation by the use of purified polysaccharides.
Polysaccharides activate acquired immunity against by-stander antigens by upregulating MHC class II molecules and cytokines produced by antigen presenting cells (APCs) such as dendritic cells. 33) These APCs capture polysaccharides and receive signals through pattern-recognition receptors, such as Toll-like receptors (TLR), C-type lectin receptors, and Nod-like receptors. 34) Since upregulation of the Ag-specific immune response has been reported in studies using laminarin 35) and -glucan, 36) and dectin-1 is designated a canonical receptor for -glucan, 16) we examined the role of dectin-1 in immunomodulation induced by oral gagome treatment. Dectin-1 is a C-type lectin that is expressed predominantly in myeloid cells such as macrophages, neutrophils, and dendritic cells, [37] [38] [39] and triggers NF-B activation in vitro and in vivo. 16, 40) To our surprise, oral gagome failed to induce Ag-specific cytokine production in the dectin-1-deficient mice.
-Glucan-dectin-1 signaling pathway have been reported to trigger T-cell priming and antibody responses. 18, 19) It is likely that oral gagome shares the mechanism stimulating APC in the intestine and activates intestinal and systemic Ag-specific T cells. Basal production of cytokines in the Ag-specific response was higher in the dectin-1-deficient mice. The reason might be that a deficiency of dectin-1 affects the expression of other immune receptors, which leads to increased production of cytokines (our unpublished observation).
PP is the primary site for the uptake and presentation of ingested Ags and an inductive site for the mucosal immune response 41) and accordingly we observed primary effect of feeding gagome in PP cells (Fig. 1) . Dectin-1 is expressed on APCs in PP (Reid et al. 42) and our unpublished observation). Thus our study suggests that gagome, and more specifically -glucan, is recognized by APC in PP and that this recognition triggers activation of T/B cells.
Our results indicate that gagome enhanced the intestinal immune response. In addition, gagome orally administered as an adjuvant was also found to induce systemic cellular and local mucosal activity. Thus, gagome can serve as a mucosal immunomodulator and adjuvant. The effect of oral gagome on cytokine production was largely dependent on the dectin-1 pathway in spite of the composite constituents of gagome (Fig. 5) . Studies of recognition of zymosan components elucidated that dectin-1 signaling has a complex pathway with recognition of TLR2 ligands. 43) To understand the complete mechanism by which oral gagome boosts host immunity, it is important to confirm whether TLR2 and other receptors are responsible for the recognition of gagome components and cell activation. 
